FdaApplication
ANDA 213465
Identifiers
- fda_app_no: ANDA213465
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2020-09-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUMATRIPTAN | SUMATRIPTAN | 20MG/SPRAY | SPRAY;NASAL |
| SUMATRIPTAN | SUMATRIPTAN | 5MG/SPRAY | SPRAY;NASAL |
2 products